Literature DB >> 20960290

Establishment of an ELISA to detect Kaposi's sarcoma-associated herpesvirus using recombinant ORF73.

Xin-xing Ouyang1, Bi-shi Fu, Bao-lin Li, Yan Zeng, Fan-hong Xu, Lin-ding Wang.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is causally related to Kaposi's sarcoma (KS), primary effusion lymphoma (PEL) and a proportion of cases of multicentric Castleman's disease (MCD). The ORF73 protein was cloned into pQE80L-orf73 and expressed in E.coli and purified. The expressed recombinant ORF73 was identified by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE). A protein of about 27 kDa was expressed as expected. Western Blotting showed that the purified recombinant ORF73 reacted with KSHV positive serum. The immunogenicity of the recombinant ORF73 was further analysed by ELISA and the optimal conditions were determined. The ORF73 ELISA was used to compare the KSHV seroprevalence between Hubei and Xinjiang Han people. The Han people in Xinjiang have significantly higher KSHV seroprevalence than their counterparts in Hubei (6.7% vs 2.9%, P = 0.005).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20960290      PMCID: PMC8227903          DOI: 10.1007/s12250-010-3106-4

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   4.327


  18 in total

1.  The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen.

Authors:  L Rainbow; G M Platt; G R Simpson; R Sarid; S J Gao; H Stoiber; C S Herrington; P S Moore; T F Schulz
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

Review 2.  Human herpesvirus 8 epidemiology: what we do and do not know.

Authors:  Nicole H Dukers; Giovanni Rezza
Journal:  AIDS       Date:  2003-08-15       Impact factor: 4.177

3.  Prevalence and age distribution of human herpesvirus-8 specific antibodies in Hungarian blood donors.

Authors:  A Juhász; E Remenyik; J Kónya; G Veress; I Andirkó; I Medgyessy; J Hunyadi; L Gergely
Journal:  J Med Virol       Date:  2001-08       Impact factor: 2.327

4.  Seroprevalence of Kaposi's sarcoma-associated herpesvirus infection among blood donors from Texas.

Authors:  J Baillargeon; J H Deng; E Hettler; C Harrison; J J Grady; L G Korte; J Alexander; E Montalvo; H B Jenson; S J Gao
Journal:  Ann Epidemiol       Date:  2001-10       Impact factor: 3.797

5.  Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma.

Authors:  E Cesarman; R G Nador; F Bai; R A Bohenzky; J J Russo; P S Moore; Y Chang; D M Knowles
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

6.  Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome.

Authors:  P Kellam; C Boshoff; D Whitby; S Matthews; R A Weiss; S J Talbot
Journal:  J Hum Virol       Date:  1997 Nov-Dec

Review 7.  Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8): epidemiology and pathogenesis.

Authors:  T F Schulz
Journal:  J Antimicrob Chemother       Date:  2000-04       Impact factor: 5.790

8.  KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma.

Authors:  S J Gao; L Kingsley; M Li; W Zheng; C Parravicini; J Ziegler; R Newton; C R Rinaldo; A Saah; J Phair; R Detels; Y Chang; P S Moore
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

9.  Human Herpesvirus 8: Biology and Role in the Pathogenesis of Kaposi's Sarcoma and Other AIDS-related Malignancies.

Authors:  Abel Viejo-Borbolla; Matthias Ottinger; Thomas F. Schulz
Journal:  Curr Infect Dis Rep       Date:  2003-04       Impact factor: 3.725

10.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease.

Authors:  J Soulier; L Grollet; E Oksenhendler; P Cacoub; D Cazals-Hatem; P Babinet; M F d'Agay; J P Clauvel; M Raphael; L Degos
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113

View more
  2 in total

1.  Prevalence and Risk Factors of Kaposi's Sarcoma-Associated Herpesvirus Infection among Han and Uygur Populations in Xinjiang, China.

Authors:  Zhi Wen; Wenli Li; Yuan Fang; Chang Zhou; Kang Lin; Huanwu Wu; Yiting Zhang; Yulin Zhu; Xingchen Xu; Yan Zeng; Baojing Lu; Linding Wang
Journal:  Can J Infect Dis Med Microbiol       Date:  2021-12-31       Impact factor: 2.471

2.  Rapid Multiplexed Immunoassay for Detection of Antibodies to Kaposi's Sarcoma-Associated Herpesvirus.

Authors:  Cathy Logan; Kathryn Todorof; Suzanne P Fiorillo; Thomas B Campbell; John H Elder; Margaret Borok; Ivy Gudza; Lovemore Gwanzura; Buxton Ndemera; Michael J Lochhead; Constance A Benson; Robert T Schooley
Journal:  PLoS One       Date:  2016-09-26       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.